Short-term outcome of neoadjuvant immunotherapy and chemotherapy in non–small cell lung cancer: A systematic review and meta-analysis

BACKGROUND: Previously reported results have shown promising efficacy of neoadjuvant immunotherapy for resectable non–small cell lung cancer (NSCLC). However, no randomized control trials comparing neoadjuvant immunotherapy with chemotherapy have yet been reported. The aim of the present study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chao, Hong, Hui-Zhao, Wu, Yi-Long, Zhong, Wen-Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Thoracic: Lung Cancer: Expert Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390514/
https://www.ncbi.nlm.nih.gov/pubmed/36004199
http://dx.doi.org/10.1016/j.xjon.2021.08.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390514/
https://www.ncbi.nlm.nih.gov/pubmed/36004199
http://dx.doi.org/10.1016/j.xjon.2021.08.036

Ejemplares similares